Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer

Nature Immunology

Volumn 2, Issue 10, 2001, Pages 962-970

  Stanislawski, Thomas ^a   Voss, Ralf Holger ^a   Lotz, Carina ^a   Sadovnikova, Elena ^b,c   Willemsen, Ralph A ^d   Kuball, Jürgen ^a   Ruppert, Thomas ^e,f   Bolhuis, Reinder L H ^d   Melief, Cornelius J ^g   Huber, Christoph ^a   Stauss, Hans J ^b   Theobald, Matthias ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c NATIONAL RESEARCH CENTER FOR HEMATOLOGY   (Russian Federation)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF MUNICH   (Germany)

^f UNIVERSITY OF HEIDELBERG   (Germany)

^g LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA A2 ANTIGEN; MURINE DOUBLE MINUTE ONCOPROTEIN 2; ONCOPROTEIN; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; TUMOR ANTIGEN; UNCLASSIFIED DRUG; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER CELL; CELL KILLING; CYTOTOXIC LYMPHOCYTE; DRUG DELIVERY SYSTEM; HUMAN; HUMAN CELL; IMMUNOTHERAPY; LYMPHOCYTE TRANSFORMATION; MALIGNANT NEOPLASTIC DISEASE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RETROVIRUS; T LYMPHOCYTE; T LYMPHOCYTE RECEPTOR GENE; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, NEOPLASM; CELL LINE; CYTOTOXICITY TESTS, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; GENE THERAPY; GENES, T-CELL RECEPTOR; HLA-A2 ANTIGEN; HUMANS; IMMUNOTHERAPY, ADOPTIVE; LEUKEMIA; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOPLASMS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; SELF TOLERANCE; T-LYMPHOCYTES, CYTOTOXIC; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0034780027     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni1001-962     Document Type: Article

References (44)

1. A new era for cancer immunotherapy based on the genes that encode cancer antigens
2. + T cell adoptive immunotherapy
3. Targeting p53 as a general tumor antigen
4. The telomerase catalytic subunit is a widely expressed tumor associated antigen recognized by cytotoxic T lymphocytes
5. Cytotoxic T cell immunity against telomerase reverse transcriptase in humans
6. Tolerance to p53 by A2.1-restricted cytotoxic T lymphocytes
7. Nucleo-cytoplasmatic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein
8. Regulation of the p53 protein by the MDM2 oncoprotein-thirty-eighth G. H. A. Clowes memorial award lecture
9. Amplification of a gene encoding a p53-associated protein in human sarcomas
10. Peptides naturally presented by MHC class I molecules
11. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules
12. ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53
13. Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide
14. Two new proteases in the MHC class I processing pathway
15. Self tolerance is H-2-restricted
16. Evidence from in vitro studies that tolerance to self antigens is MHC-restricted
17. On the nature of peptides involved in T cell alloreactivity
18. Peptide-specific cytotoxic T lymphocytes restricted by nonself major histocompatibility complex class I molecules: Reagents for tumor immunotherapy
19. Generation of human tumor-reactive cytotoxic T cells against peptide presented by non-self HLA class I molecules
20. Alloreactivity as a source of high avidity peptide-specific human CTL
21. Immunotherapy with CTLs restricted by nonself MHC
22. Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligands
23. Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells
24. Efficient generation of a hepatitis B virus cytotoxic T lymphocyte epitope requires the structural features of immunoproteasomes
25. Molecular cloning of the mouse proteasome subunits MC14 and MECL-1: Reciprocally regulated tissue expression of interferon-γ-modulated proteasome subunits
26. In thymic selection, peptide diversity gives and takes away
27. +T cells resulting in a failure to lyse tumor cells
28. Ligand thresholds at different stages of T cell development
29. Lower receptor avidity required for thymic clonal deletion than for effector T-cell function
30. In vitro evolution of a T cell receptor with high affinity for peptide/MHC
31. Breaking the affinity ceiling for antibodies and T cell receptors
32. Changing T cell specificity by retroviral T cell receptor display
33. Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity
34. Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR
35. Transfer of specificity for human immunodeficiency virus type I into primary human T lymphocytes by introduction of T-cell receptor genes
36. Retroviral transduction of a T cell receptor specific for an Epstein-Barr virus-encoded peptide
37. Immunotherapy through TCR gene transfer
38. Maintenance of TCR clonality in T cells expressing genes for two TCR heterodimers
39. A general method for facilitating heterodimeric pairing between two proteins: Application to expression of α and β T-cell receptor extracellular elements
40. Peptide 'velcro': Design of a heterodimeric coiled coil
41. Selecting T cell receptors with high affinity for self-MHC by decreasing the contribution of CD8
42. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions
43. Modified vaccinia virus ankara for delivery of human tyrosinase as melanoma-associated antigen: Induction of tyrosinase- and melanoma-specific human leukocyte antigen A*0201-restricted cytotoxic T cells in vitro and in vivo
44. The sequence alteration associated with a mutational hotspot in p53 protects cells from lysis by cytotoxic T lymphocytes specific for a flanking peptide epitope